250 Philly Risperdal Suits May Be Time-Barred, Judge Says

By Matt Fair (September 24, 2015, 5:13 PM EDT) -- A Pennsylvania state judge said Tuesday that he would ax more than 250 cases a Johnson & Johnson unit is facing over abnormal breast growth allegedly caused by the antipsychotic drug Risperdal if an appeals court upholds his conclusions about when statutes of limitations accrued in the litigation....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!